BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu GY, Chen HS. Novel approaches towards conquering hepatitis B virus infection. World J Gastroenterol 2007; 13(6): 830-836 [PMID: 17352010 DOI: 10.3748/wjg.v13.i6.830]
URL: https://www.wjgnet.com/1007-9327/full/v13/i6/830.htm
Number Citing Articles
1
Wei Jia, Yanfang Zhao, Rongdong Li, Yanjiao Wu, Zebiao Li, Ping Gong. Synthesis and In‐Vitro Anti‐Hepatitis‐B Virus Activity of 6H‐[1]Benzothiopyrano[4,3‐b] quinolin‐10‐olsArchiv der Pharmazie 2009; 342(9): 507 doi: 10.1002/ardp.200900070
2
Zhanpeng Yan, Tingting Xu, Kelei Su, Chi Wang, Tong Yan, Zhong Hua, Erli Gu, Fangshi Zhu, J.Q. Cheng, H.L. Moffitt, I. Kim, Z.T. Chi, J. Zhang. Investigation of therapeutic effect of Longchai Formula Granule on chronic hepatitis B patients: A double-blind, controlled and randomized clinical trialBIO Web of Conferences 2017; 8: 01029 doi: 10.1051/bioconf/20170801029
3
F. Bohne, U. Protzer. Adoptive T‐cell therapy as a therapeutic option for chronic hepatitis BJournal of Viral Hepatitis 2007; 14(s1): 45 doi: 10.1111/j.1365-2893.2007.00913.x
4
Ke-lei Su, Fang-shi Zhu. Effect of LongChai decoction-containing serum on the secretion of HBsAg, HBeAg and cell cycle in HepG2.2.15 Cells2012 International Symposium on Information Technologies in Medicine and Education 2012; : 845 doi: 10.1109/ITiME.2012.6291435
5
Fan Zhang, Gang Wang. A review of non-nucleoside anti-hepatitis B virus agentsEuropean Journal of Medicinal Chemistry 2014; 75: 267 doi: 10.1016/j.ejmech.2014.01.046
6
Yong-Song Guan, Qing He, Ming-Quan Wang, Ping Li. Nuclear factor kappa B and hepatitis virusesExpert Opinion on Therapeutic Targets 2008; 12(3): 265 doi: 10.1517/14728222.12.3.265
7
Rebecca Pastor, François Habersetzer, Samira Fafi-Kremer, Michel Doffoël, Thomas F Baumert, Jean-Pierre Gut, Françoise Stoll-Keller, Evelyne Schvoerer. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patientsWorld Journal of Gastroenterology 2009; 15(6): 753-755 doi: 10.3748/wjg.15.753
8
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis BDrugs 2017; 77(12): 1263 doi: 10.1007/s40265-017-0769-2
9
Stephan Urban, Ulrike Protzer. Comparative Hepatitis2008; : 75 doi: 10.1007/978-3-7643-8558-3_4
10
Li-Jun Wang, Chang-An Geng, Yun-Bao Ma, Jie Luo, Xiao-Yan Huang, Hao Chen, Ning-Jia Zhou, Xue-Mei Zhang, Ji-Jun Chen. Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agentsEuropean Journal of Medicinal Chemistry 2012; 54: 352 doi: 10.1016/j.ejmech.2012.05.012
11
Xiaoyang Bi, Meihong Lin, Yifeng Zhou, Dandan Li, Zuowei Xu, Lijuan Zhou, Jiguang Huang. Insecticidal Activity and Molecular Target by Morphological Analysis, RNAseq, and Molecular Docking of the Aryltetralin Lignan Lactone Helioxanthin, Isolated from Taiwania flousiana GaussenJournal of Agricultural and Food Chemistry 2024; 72(10): 5133 doi: 10.1021/acs.jafc.3c06384
12
Rui-Hua Guo, Quan Zhang, Yun-Bao Ma, Xiao-Yan Huang, Jie Luo, Li-Jun Wang, Chang-An Geng, Xue-Mei Zhang, Jun Zhou, Zhi-Yong Jiang, Ji-Jun Chen. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agentsBioorganic & Medicinal Chemistry 2011; 19(4): 1400 doi: 10.1016/j.bmc.2011.01.006
13
Thu Kim Nguyen, Duyet Van Le. Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in VietnamJournal of Global Antimicrobial Resistance 2023; 33: 35 doi: 10.1016/j.jgar.2023.02.013
14
Steven K. Herrine, Simona Rossi, Victor J. Navarro. Pharmacology and Therapeutics2009; : 527 doi: 10.1016/B978-1-4160-3291-5.50039-1
15
Sundeep Kumar Goyal, Vinod Kumar Dixit, Suneet Kumar Shukla, Jayant Ghosh, Manas Behera, Manish Tripathi, Neha Gupta, Arttrika Ranjan, Ashok Kumar Jain. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosisIndian Journal of Gastroenterology 2015; 34(4): 286 doi: 10.1007/s12664-015-0576-1
16
Guo-Yi Wu, Xiao-Jing Zheng, Chang-Cheng Yin, Dong Jiang, Ling Zhu, Yan Liu, Lai Wei, Yu Wang, Hong-Song Chen. Inhibition of Hepatitis B Virus Replication by Bay 41-4109 and Its Association with Nucleocapsid DisassemblyJournal of Chemotherapy 2008; 20(4): 458 doi: 10.1179/joc.2008.20.4.458